Everist Announces Advance In Diagnosis, Prognosis Of Colorectal CancerEverist Genomics, a rapidly growing personalized medicine company, today announced the launch of the world's first comprehensive companion diagnostics and prognostics portfolio to improve early diagnosis, management and treatment of patients with colorectal cancer.
Rubicon Genomics Signs Deal For Technology With AgendiaAnn Arbor-based Rubicon Genomics Inc. said Thursday that it had a new clinical supply agreement with the Amsterdam, Netherlands-based diagnostics firm Agendia.

More From CBS Detroit

Best Places To See Indie Rock In DetroitIt's called Detroit Rock City for a reason.
Guide: Best Barbecue In Metro DetroitSometimes, nothing hits the spot like good barbecue.
Best Ice Cream Shops In Metro DetroitIt's getting warm outside! Take advantage of it.

Watch & Listen